NCT06215820 - Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Bunionectomy | Biotech Hunter

Enrollment

410

Participants

Timeline

Start Date

December 29, 2023

Primary Completion Date

August 24, 2024

Study Completion Date

September 30, 2024

Conditions

Acute PainPost Operative PainPain

Interventions

DRUG

MR-107A-02

tablet

DRUG

Tramadol

over-encapsulated tablet

DRUG

Placebo

over-encapsulated tablet and/or tablet

PROCEDURE

Bunionectomy

Primary unilateral bunionectomy with first metatarsal osteotomy under regional anesthesia

Trial Locations (15)

21122

Investigator site 102, Pasadena

30331

Investigator site 109, Atlanta

33613

Investigator site 108, Tampa

35660

Investigator site 114, Sheffield

Investigator site 112, Miami

62269

Investigator site 104, O'Fallon

Investigator site 105, San Antonio

75007

Investigator site 107, Carrollton

77008

Investigator site 106, Houston

77401

Investigator site 113, Bellaire

78501

Investigator site 111, McAllen

84107

Investigator site 101, Salt Lake City

85053

Investigator site 115, Phoenix

92501

Investigator site 110, Riverside

92801

Investigator site 103, Anaheim

All Listed Sponsors

collaborator

Mylan Specialty, LP

INDUSTRY

lead

Viatris Specialty LLC

INDUSTRY